Clinical Relevance Versus Statistical Significance: DelBello and Colleagues Respond to Editorial.
We would like to respond to some concerns raised by Dr. McClellan in his editorial comment1 on our article that reported the results of a placebo-controlled study of lurasidone for the treatment of children and adolescents with bipolar I depression.2.